Skip to main content
QIAGEN N.V.
Healthcare · Diagnostics & Research
Made on Aug 5, 2026
Price at call $42.33
6-month call Bear -5.5%
Target by Feb 2027 $40.00
Great value below $34.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -5.5% to $40.00
Predicted High $42.10 in 2 weeks
Predicted Low $40.00 at 6 months
Max Drawdown (predicted) -5.5%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 5, 2026 2:40 am
Bear QGEN trends lower to $40.00 (-5.5% from $42.33) by Feb 2027. decay
ThesisQGEN trades slightly above composite fair value with weak sentiment and quality offsets, but low beta and dull narrative mean gravity toward $40 is gradual. Absent a catalyst and with no earnings print in the window, expect a mild drift lower toward deserved value, stabilizing near $40.
Invalidated ifA close above $46 or below $36 within 2 months, or an unscheduled earnings/guidance event.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $42.33 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 5, 2026 $42.33 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 19, 2026 $39.54–$45.12 typical range · internal point $42.10 ±6.6% 6/10 Low-vol drift, risk-on tape offers slight support
What actually happened: closed $43.76 on Aug 19, 2026 = +3.4% vs the call (predicted -0.5%)  ·  direction HIT (called flat, was flat)  ·  off by 3.9 pp  ·  accuracy 9/10  ·  typical range ±6.6%: inside the band  ·  S&P +0.2% over the same window — lagged it
1 month Sep 5, 2026 $38.29–$46.37 typical range · internal point $41.70 ±9.6% 6/10 Slow mean reversion toward composite fair value
2 months Oct 5, 2026 $41.20 -2.7% 5/10 Value gravity compounds, no catalyst to lift
3 months Nov 5, 2026 $40.60 -4.1% 5/10 Approaches deserved value near $40.79
4 months Dec 5, 2026 $40.30 -4.8% 4/10 Settles near composite fair value zone
5 months Jan 5, 2027 $40.10 -5.3% 4/10 Quiet consolidation, minimal macro sensitivity
6 months Feb 5, 2027 $40.00 -5.5% 4/10 Anchored at fair value absent new catalyst

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $42.05 (-0.7%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$42.33
Composite fair value$40.33
Signal-adjusted fair value$40.34
DCF fair value$38.11
Anchored-PE fair value$66.65
Buy-below (value lens)$34.00
Value net score-49
Value confidence7 / 10
Quality net score+20
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 39.2%  3m 33.1%  6m 34.5%  
Daily σ (realism noise)2.1%
Beta vs S&P 500 1m 0.62  3m 0.40  5m 0.76  
Trailing 6-month return-18.9%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 3, 2026 freshest QGEN-20260803-164946-ca7b
ext-forensic-memo Aug 3, 2026 freshest ext-QGEN-20260803-175115-26b0
ext-lens-quality Aug 3, 2026 freshest ext-QGEN-20260803-175115-26b0
ext-lens-sentiment Aug 3, 2026 freshest ext-QGEN-20260803-175115-26b0
ext-lens-value Aug 3, 2026 freshest ext-QGEN-20260803-175115-26b0
scenario-valuation Aug 3, 2026 freshest QGEN-20260803-164946-ca7b
valuation-synthesis Aug 3, 2026 freshest QGEN-20260803-164946-ca7b

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

1 frozen snapshot — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 5, 2026 v0.6.0 Bear $42.33 $40.00 -5.5% Feb 2027 viewing

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.